Filing Details

Accession Number:
0001062993-22-019850
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-22 11:46:51
Reporting Period:
2022-09-20
Accepted Time:
2022-09-22 11:46:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799011 Lucid Diagnostics Inc. LUCD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678195 Stanley Lapidus One Grand Central Place, Suite 4600
New York NY 10165
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-20 17,000 $1.71 152,320 No 4 S Direct
Common Stock Disposition 2022-09-20 16,864 $1.70 135,456 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
  2. Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.